IBDEI07K ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9911,1,3,0)
 ;;=3^Cataract, Unspecified
 ;;^UTILITY(U,$J,358.3,9911,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,9911,2)
 ;;=Cataract, Unspecified^20266
 ;;^UTILITY(U,$J,358.3,9912,0)
 ;;=362.83^^63^619^31
 ;;^UTILITY(U,$J,358.3,9912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9912,1,3,0)
 ;;=3^Macular Edema (CSME)
 ;;^UTILITY(U,$J,358.3,9912,1,4,0)
 ;;=4^362.83
 ;;^UTILITY(U,$J,358.3,9912,2)
 ;;=Macular Edema^89576
 ;;^UTILITY(U,$J,358.3,9913,0)
 ;;=362.52^^63^619^11
 ;;^UTILITY(U,$J,358.3,9913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9913,1,3,0)
 ;;=3^Cystoid Macular Degeneration
 ;;^UTILITY(U,$J,358.3,9913,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,9913,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,9914,0)
 ;;=367.22^^63^619^29
 ;;^UTILITY(U,$J,358.3,9914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9914,1,3,0)
 ;;=3^Irregular Astigmatism
 ;;^UTILITY(U,$J,358.3,9914,1,4,0)
 ;;=4^367.22
 ;;^UTILITY(U,$J,358.3,9914,2)
 ;;=^265373
 ;;^UTILITY(U,$J,358.3,9915,0)
 ;;=V45.69^^63^619^44
 ;;^UTILITY(U,$J,358.3,9915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9915,1,3,0)
 ;;=3^States Following Surg of Eye
 ;;^UTILITY(U,$J,358.3,9915,1,4,0)
 ;;=4^V45.69
 ;;^UTILITY(U,$J,358.3,9915,2)
 ;;=^317957
 ;;^UTILITY(U,$J,358.3,9916,0)
 ;;=V58.71^^63^619^4
 ;;^UTILITY(U,$J,358.3,9916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9916,1,3,0)
 ;;=3^Aftercare Following Surg of Sense Organ
 ;;^UTILITY(U,$J,358.3,9916,1,4,0)
 ;;=4
 ;;^UTILITY(U,$J,358.3,9916,2)
 ;;=^328689
 ;;^UTILITY(U,$J,358.3,9917,0)
 ;;=V45.61^^63^619^9
 ;;^UTILITY(U,$J,358.3,9917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9917,1,3,0)
 ;;=3^Cataract Extraction Status
 ;;^UTILITY(U,$J,358.3,9917,1,4,0)
 ;;=4^V45.61
 ;;^UTILITY(U,$J,358.3,9917,2)
 ;;=^295462
 ;;^UTILITY(U,$J,358.3,9918,0)
 ;;=V72.0^^63^619^21
 ;;^UTILITY(U,$J,358.3,9918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9918,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,9918,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,9918,2)
 ;;=^43432
 ;;^UTILITY(U,$J,358.3,9919,0)
 ;;=V71.89^^63^619^34
 ;;^UTILITY(U,$J,358.3,9919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9919,1,3,0)
 ;;=3^Observe SPEC Condition
 ;;^UTILITY(U,$J,358.3,9919,1,4,0)
 ;;=4^V71.89
 ;;^UTILITY(U,$J,358.3,9919,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,9920,0)
 ;;=V50.1^^63^619^35
 ;;^UTILITY(U,$J,358.3,9920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9920,1,3,0)
 ;;=3^Oth Plastic Surgery
 ;;^UTILITY(U,$J,358.3,9920,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,9920,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,9921,0)
 ;;=368.8^^63^619^36
 ;;^UTILITY(U,$J,358.3,9921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9921,1,3,0)
 ;;=3^Oth Specific Visual Disturbances
 ;;^UTILITY(U,$J,358.3,9921,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,9921,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,9922,0)
 ;;=368.13^^63^619^37
 ;;^UTILITY(U,$J,358.3,9922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9922,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,9922,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,9922,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,9923,0)
 ;;=998.59^^63^619^38
 ;;^UTILITY(U,$J,358.3,9923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9923,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,9923,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,9923,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,9924,0)
 ;;=368.03^^63^619^5
 ;;^UTILITY(U,$J,358.3,9924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9924,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,9924,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,9924,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,9925,0)
 ;;=367.31^^63^619^6
 ;;^UTILITY(U,$J,358.3,9925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9925,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,9925,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,9925,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,9926,0)
 ;;=367.20^^63^619^7
 ;;^UTILITY(U,$J,358.3,9926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9926,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,9926,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,9926,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,9927,0)
 ;;=367.0^^63^619^28
 ;;^UTILITY(U,$J,358.3,9927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9927,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,9927,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,9927,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,9928,0)
 ;;=367.1^^63^619^33
 ;;^UTILITY(U,$J,358.3,9928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9928,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,9928,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,9928,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,9929,0)
 ;;=V43.1^^63^619^41
 ;;^UTILITY(U,$J,358.3,9929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9929,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,9929,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,9929,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,9930,0)
 ;;=367.9^^63^619^43
 ;;^UTILITY(U,$J,358.3,9930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9930,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,9930,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,9930,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,9931,0)
 ;;=365.04^^63^619^25
 ;;^UTILITY(U,$J,358.3,9931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9931,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,9931,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,9931,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,9932,0)
 ;;=365.01^^63^619^27
 ;;^UTILITY(U,$J,358.3,9932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9932,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,9932,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,9932,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,9933,0)
 ;;=365.71^^63^619^23
 ;;^UTILITY(U,$J,358.3,9933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9933,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,9933,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,9933,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,9934,0)
 ;;=365.72^^63^619^24
 ;;^UTILITY(U,$J,358.3,9934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9934,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,9934,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,9934,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,9935,0)
 ;;=365.73^^63^619^26
 ;;^UTILITY(U,$J,358.3,9935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9935,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,9935,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,9935,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,9936,0)
 ;;=362.51^^63^619^1
 ;;^UTILITY(U,$J,358.3,9936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9936,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,9936,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,9936,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,9937,0)
 ;;=362.52^^63^619^2
 ;;^UTILITY(U,$J,358.3,9937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9937,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,9937,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,9937,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,9938,0)
 ;;=362.04^^63^619^14
 ;;^UTILITY(U,$J,358.3,9938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9938,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,9938,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,9938,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,9939,0)
 ;;=362.05^^63^619^15
 ;;^UTILITY(U,$J,358.3,9939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9939,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,9939,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,9939,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,9940,0)
 ;;=362.06^^63^619^17
 ;;^UTILITY(U,$J,358.3,9940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9940,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,9940,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,9940,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,9941,0)
 ;;=362.02^^63^619^16
 ;;^UTILITY(U,$J,358.3,9941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9941,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,9941,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,9941,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,9942,0)
 ;;=379.39^^63^619^42
 ;;^UTILITY(U,$J,358.3,9942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9942,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,9942,1,4,0)
 ;;=4^379.39
 ;;^UTILITY(U,$J,358.3,9942,2)
 ;;=^87515
 ;;^UTILITY(U,$J,358.3,9943,0)
 ;;=367.9^^63^619^18
 ;;^UTILITY(U,$J,358.3,9943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9943,1,3,0)
 ;;=3^Disorder of Refraction
 ;;^UTILITY(U,$J,358.3,9943,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,9943,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,9944,0)
 ;;=373.2^^63^619^32
 ;;^UTILITY(U,$J,358.3,9944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9944,1,3,0)
 ;;=3^Meibomianitis
 ;;^UTILITY(U,$J,358.3,9944,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,9944,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,9945,0)
 ;;=V58.69^^63^619^30
 ;;^UTILITY(U,$J,358.3,9945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9945,1,3,0)
 ;;=3^Long Term Use of Medication
 ;;^UTILITY(U,$J,358.3,9945,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,9945,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,9946,0)
 ;;=379.24^^63^619^46
 ;;^UTILITY(U,$J,358.3,9946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9946,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,9946,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,9946,2)
 ;;=^88242
 ;;^UTILITY(U,$J,358.3,9947,0)
 ;;=373.32^^64^620^48
 ;;^UTILITY(U,$J,358.3,9947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9947,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,9947,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,9947,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,9948,0)
 ;;=373.00^^64^620^4
 ;;^UTILITY(U,$J,358.3,9948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9948,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,9948,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,9948,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,9949,0)
 ;;=373.2^^64^620^7
 ;;^UTILITY(U,$J,358.3,9949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9949,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,9949,1,4,0)
 ;;=4^373.2
